TY - JOUR
T1 - Hepatorenal syndrome
T2 - A proposal for kidney after liver transplantation (KALT)
AU - Ruiz, Richard
AU - Barri, Yousri M.
AU - Jennings, Linda W.
AU - Chinnakotla, Srinath
AU - Goldstein, Robert M.
AU - Levy, Marlon F.
AU - McKenna, Greg J.
AU - Randall, Henry B.
AU - Sanchez, Edmund Q.
AU - Klintmalm, Goran B.
PY - 2007/6
Y1 - 2007/6
N2 - Hepatorenal syndrome (HRS) is a well-recognized complication of end-stage liver disease. Once thought to be a reversible condition with liver transplantation (LT) alone, HRS may directly contribute to the requirement for long-term dialysis posttransplant. As a result, discussion has now focused on whether or when a kidney allograft should be considered for these patients. Using the International Ascites Club guidelines with a pretransplant serum creatinine (SCr) >2.0 mg/dL to define HRS, 130 patients undergoing LT over a 10-yr period were identified, for an overall incidence of 9%. Patient survival rates at 1, 3, and 5 yr were 74%, and 68%, and 62%, respectively. Survival was significantly worse when compared to non-HRS patients undergoing LT over the same study period (P = 0.0001). For patients presenting with type 2 HIRS, 7 patients (6%) developed irreversible kidney failure posttransplant compared to 0.34% in the non-HRS population (P < 0.0001). Five of these patients died within 1 yr with a median survival time of 139 days. Combined liver and kidney transplantation (CLKT) for patients with HRS is not recommended. However, an improvement in outcome can be accomplished by addressing those patients who require dialysis greater than 60 days posttransplant. We propose a role for kidney after liver transplantation (KALT) in select HRS patients.
AB - Hepatorenal syndrome (HRS) is a well-recognized complication of end-stage liver disease. Once thought to be a reversible condition with liver transplantation (LT) alone, HRS may directly contribute to the requirement for long-term dialysis posttransplant. As a result, discussion has now focused on whether or when a kidney allograft should be considered for these patients. Using the International Ascites Club guidelines with a pretransplant serum creatinine (SCr) >2.0 mg/dL to define HRS, 130 patients undergoing LT over a 10-yr period were identified, for an overall incidence of 9%. Patient survival rates at 1, 3, and 5 yr were 74%, and 68%, and 62%, respectively. Survival was significantly worse when compared to non-HRS patients undergoing LT over the same study period (P = 0.0001). For patients presenting with type 2 HIRS, 7 patients (6%) developed irreversible kidney failure posttransplant compared to 0.34% in the non-HRS population (P < 0.0001). Five of these patients died within 1 yr with a median survival time of 139 days. Combined liver and kidney transplantation (CLKT) for patients with HRS is not recommended. However, an improvement in outcome can be accomplished by addressing those patients who require dialysis greater than 60 days posttransplant. We propose a role for kidney after liver transplantation (KALT) in select HRS patients.
UR - http://www.scopus.com/inward/record.url?scp=34250172894&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34250172894&partnerID=8YFLogxK
U2 - 10.1002/lt.21149
DO - 10.1002/lt.21149
M3 - Article
C2 - 17539003
AN - SCOPUS:34250172894
SN - 1527-6465
VL - 13
SP - 838
EP - 843
JO - Liver Transplantation
JF - Liver Transplantation
IS - 6
ER -